000 | 01175 a2200325 4500 | ||
---|---|---|---|
005 | 20250513132853.0 | ||
264 | 0 | _c19980202 | |
008 | 199802s 0 0 eng d | ||
022 | _a1060-0280 | ||
024 | 7 |
_a10.1177/106002809703101209 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMauro, L S | |
245 | 0 | 0 |
_aIntroduction to coronary artery stents and their pharmacotherapeutic management. _h[electronic resource] |
260 |
_bThe Annals of pharmacotherapy _cDec 1997 |
||
300 |
_a1490-8 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAnticoagulants _xadverse effects |
650 | 0 | 4 |
_aCoronary Disease _xetiology |
650 | 0 | 4 |
_aCoronary Thrombosis _xetiology |
650 | 0 | 4 | _aEquipment Design |
650 | 0 | 4 |
_aHemorrhage _xchemically induced |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aSecondary Prevention |
650 | 0 | 4 |
_aStents _xadverse effects |
700 | 1 | _aBorovicka, M C | |
700 | 1 | _aKline, S S | |
773 | 0 |
_tThe Annals of pharmacotherapy _gvol. 31 _gno. 12 _gp. 1490-8 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/106002809703101209 _zAvailable from publisher's website |
999 |
_c9385962 _d9385962 |